Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Infectious Mastitis During Lactation
NCT00716183Phase 3Completed
- Sponsor
- Complutense University of Madrid
- Start
- Jul 2008
- Primary completion
- Jul 2008
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lactobacillus salivarius HN6, lactobacillus reuteri cr20 and Lactobacillus fermentum LC40 in mastitis (4 arms), sponsored by Complutense University of Madrid. Primary endpoint: Staphylococcal and/or streptococcal count in milk at Day 28. Started Jul 2008; status: completed.
02
Drugs
lactobacillus salivarius HN6lactobacillus reuteri cr20Lactobacillus fermentum LC40
03
Conditions
mastitis
Beyond the preview
Go deeper on NCT00716183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00716183.